a public good project by the
Synthesis
Company
of California

© 2026

Eric Ding | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Eric Ding

Idera Pharmaceuticals (United States)(US)Biogen (Switzerland)(CH)

Research Areas

Lymphoma Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications

Most-Cited Works

→ Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma(2000)234 cited